| Key Financial Ratios of Strides Pharma Science (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
313.68 |
7.20 |
0.52 |
20.08 |
8.73 |
|
| Diluted EPS (Rs.) |
313.65 |
7.19 |
0.52 |
20.07 |
8.72 |
|
| Cash EPS (Rs.) |
322.34 |
16.34 |
10.89 |
31.69 |
19.80 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
346.42 |
387.50 |
382.61 |
379.36 |
362.18 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
346.42 |
387.50 |
382.61 |
379.36 |
362.18 |
|
| Dividend / Share(Rs.) |
4.00 |
2.50 |
0.00 |
0.00 |
2.50 |
|
| Revenue from Operations/Share (Rs.) |
232.13 |
234.30 |
205.36 |
220.40 |
207.13 |
|
| PBDIT/Share (Rs.) |
33.49 |
35.65 |
20.21 |
22.29 |
30.81 |
|
| PBIT/Share (Rs.) |
24.31 |
26.43 |
9.85 |
10.66 |
19.73 |
|
| PBT/Share (Rs.) |
8.47 |
7.58 |
-7.17 |
2.40 |
12.45 |
|
| Net Profit/Share (Rs.) |
313.16 |
7.13 |
0.52 |
20.07 |
8.72 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
14.42 |
15.21 |
9.84 |
10.11 |
14.87 |
|
| PBIT Margin (%) |
10.47 |
11.28 |
4.79 |
4.83 |
9.52 |
|
| PBT Margin (%) |
3.64 |
3.23 |
-3.49 |
1.08 |
6.00 |
|
| Net Profit Margin (%) |
134.90 |
3.04 |
0.25 |
9.10 |
4.21 |
|
| Return on Networth / Equity (%) |
90.39 |
1.83 |
0.13 |
5.28 |
2.40 |
|
| Return on Capital Employed (%) |
6.58 |
6.32 |
2.32 |
2.66 |
4.87 |
|
| Return on Assets (%) |
57.36 |
1.12 |
0.08 |
3.31 |
1.49 |
|
| Total Debt/Equity (X) |
0.36 |
0.45 |
0.39 |
0.37 |
0.26 |
|
| Asset Turnover Ratio (%) |
0.39 |
0.38 |
0.34 |
0.37 |
0.38 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.32 |
1.21 |
1.18 |
1.07 |
1.10 |
|
| Quick Ratio (X) |
1.05 |
0.98 |
0.91 |
0.79 |
0.66 |
|
| Inventory Turnover Ratio (X) |
4.74 |
2.23 |
2.03 |
1.56 |
1.85 |
|
| Dividend Payout Ratio (NP) (%) |
0.79 |
20.68 |
0.00 |
0.00 |
22.89 |
|
| Dividend Payout Ratio (CP) (%) |
0.77 |
9.02 |
0.00 |
0.00 |
10.08 |
|
| Earnings Retention Ratio (%) |
99.21 |
79.32 |
0.00 |
0.00 |
77.11 |
|
| Cash Earnings Retention Ratio (%) |
99.23 |
90.98 |
0.00 |
0.00 |
89.92 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
7,291.46 |
8,674.44 |
3,847.64 |
4,341.86 |
8,341.56 |
|
| EV/Net Operating Revenue (X) |
3.41 |
4.03 |
2.07 |
2.19 |
4.49 |
|
| EV/EBITDA (X) |
23.63 |
26.48 |
21.08 |
21.70 |
30.19 |
|
| MarketCap/Net Operating Revenue (X) |
2.88 |
3.34 |
1.39 |
1.57 |
4.08 |
|
| Retention Ratios (%) |
99.20 |
79.31 |
0.00 |
0.00 |
77.10 |
|
| Price/BV (X) |
1.93 |
2.02 |
0.75 |
0.91 |
2.33 |
|
| Price/Net Operating Revenue |
2.88 |
3.34 |
1.39 |
1.57 |
4.08 |
|
| Earnings Yield |
0.47 |
0.01 |
0.00 |
0.06 |
0.01 |
|
Source : Dion Global Solutions Limited
